,for, Item ID-
  • #1254852
  • Microgenics #10016421

Toxicology Reagent CEDIA® Methadone Metabolite (EDDP) CLIA Non-Waived For Clinical Chemistry Analyzers

REAGENT, IMMUNOASSAY CEDIA METHADONE METABOLITE 3X17ML

No Image

Features

  • The CEDIA Methadone Metabolite Assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative assay of EDDP (2-ethylidine-1, 5-dimethyl-3, 3-diphenylpyrrolidine) in human urine
  • Measurements are used as an aid in the diagnosis and treatment of methadone use or overdose
  • The CEDIA Methadone Metabolite assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
  • More …
  Log In to Order
or

Product Specifications


Features
  • The CEDIA Methadone Metabolite Assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative assay of EDDP (2-ethylidine-1, 5-dimethyl-3, 3-diphenylpyrrolidine) in human urine
  • Measurements are used as an aid in the diagnosis and treatment of methadone use or overdose
  • The CEDIA Methadone Metabolite assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
  • Qualitative or semi-quantitative options for results
  • Excellent correlation to GC/MS

Professionals Also Viewed